Menu
Back to User profile » Dr Zhigang Wei
Papers published by Dr Zhigang Wei:
Retraction
The Prognostic Value of LINC01296 in Pan-Cancers and the Molecular Regulatory Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on Data Mining, Bioinformatics, and in vitro Validation [Retraction]
Liang C, Zhang Y, Zhang Y, Li R, Wang Z, Wei Z, Guo J
OncoTargets and Therapy 2020, 13:2525-2526
Published Date: 26 March 2020
Retraction
The Long Non-Coding RNA SBF2-AS1 Exerts Oncogenic Functions in Gastric Cancer by Targeting the miR-302b-3p/E2F Transcription Factor 3 Axis [Retraction]
Liang C, Yue C, Liang C, Ge H, Wei Z, Li G, Wu J, Huang H, Guo J
OncoTargets and Therapy 2020, 13:2523-2524
Published Date: 26 March 2020
Original Research
The Long Non-Coding RNA SBF2-AS1 Exerts Oncogenic Functions In Gastric Cancer By Targeting The miR-302b-3p/E2F Transcription Factor 3 Axis
Liang C, Yue C, Liang C, Ge H, Wei Z, Li G, Wu J, Huang H, Guo J
OncoTargets and Therapy 2019, 12:8879-8893
Published Date: 30 October 2019
Original Research
The prognostic value of LINC01296 in pan-cancers and the molecular regulatory mechanism in hepatocellular carcinoma: a comprehensive study based on data mining, bioinformatics, and in vitro validation
Liang C, Zhang Y, Zhang Y, Li R, Wang Z, Wei Z, Guo J
OncoTargets and Therapy 2019, 12:5861-5885
Published Date: 19 July 2019
Original Research
Pseudogene DUXAP10 acts as a diagnostic and prognostic marker and promotes cell proliferation by activating PI3K/AKT pathway in hepatocellular carcinoma
Yue C, Liang C, Ge H, Yan L, Xu Y, Li G, Li P, Wei Z, Wu J
OncoTargets and Therapy 2019, 12:4555-4566
Published Date: 11 June 2019